Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi

• Päätekijät: Thulani Maphosa (Tekijä), Shalom Dunga (Tekijä), Lucky Makonokaya (Tekijä), Godfrey Woelk (Tekijä), Alice Maida (Tekijä), Alice Wang (Tekijä), Allan Ahimbisibwe (Tekijä), Rachel K. Chamanga (Tekijä), Suzgo B. Zimba (Tekijä), Dumbani Kayira (Tekijä), Rhoderick Machekano (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2024-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background The introduction of dolutegravir (DTG) in treating HIV has shown enhanced efficacy and tolerability. This study examined changes in weight gain and body mass index (BMI) at 6- and 12-months after post-initiating antiretroviral therapy (ART), comparing people living with HIV (PLHI...